Disease activity score in a large placebo-controlled randomized study of rheumatoid arthritis patients treated with Anakinra (Kineret®)

被引:0
|
作者
Shergy, WJ
Kaine, JL
Hurd, ER
Cohen, SB
Roth, S
Brodsky, A
Block, SR
Sun, G
Modafferi, D
Eickenhorst, T
Leff, J
机构
[1] Sarasota Arthrit Ctr, Sarasota, FL USA
[2] St Paul Med Ctr, Dept Rheumatol, Dallas, TX USA
[3] Arizona Res & Educ, Phoenix, AZ USA
[4] Arthrit Care & Diagnost Ctr, Dallas, TX USA
[5] Amgen Inc, Dev, Thousand Oaks, CA 91320 USA
[6] Amgen Inc, Med Affairs, Thousand Oaks, CA 91320 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:186 / 186
页数:1
相关论文
共 50 条
  • [1] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ANAKINRA IN PATIENTS WITH STILL′S DISEASE
    Schanberg, L.
    Nigrovic, P.
    Cooper, A.
    Chatham, W.
    Akoghlanian, S.
    Singh, N.
    Rabinovich, E.
    Thatayatikom, A.
    Taxter, A.
    Hausmann, J.
    Zdravkovic, M.
    Ohlman, S.
    Andersson, H.
    Cederholm, S.
    Wiken, M.
    Schneider, R.
    De Benedetti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1815 - 1816
  • [2] A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
    Cohen, SB
    Moreland, LW
    Cush, JJ
    Greenwald, MW
    Block, S
    Shergy, WJ
    Hanrahan, PS
    Khraishi, MM
    Patel, A
    Sun, G
    Bear, MB
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1062 - 1068
  • [3] A randomized placebo-controlled trial on the effect of high dose (intravenously) pamidronate on disease activity in patients with rheumatoid arthritis.
    Lodder, MC
    van Pelt, PA
    Kostense, PJ
    Lems, WF
    Koks, CHW
    Dijkmans, BAC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S516 - S516
  • [4] Anakinra (recombinant interleukin-1 receptor antagonist): A large, placebo controlled efficacy trial of anakinra in patients with erosive rheumatoid arthritis disease
    Cohen, SB
    Moreland, LW
    Cush, JJ
    Greenwald, MW
    Block, JA
    Shergy, WJ
    Hanrahan, PS
    Khraishi, MM
    Patel, A
    Sun, G
    Bear, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2946 - 2946
  • [5] The effect of acupuncture on patients with rheumatoid arthritis: a randomized, placebo-controlled cross-over study
    David, J
    Townsend, S
    Sathanathan, R
    Kriss, S
    Dore, CJ
    RHEUMATOLOGY, 1999, 38 (09) : 864 - 869
  • [6] Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial
    Bresnihan, B
    Newmark, R
    Robbins, S
    Genant, HK
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (06) : 1103 - 1111
  • [7] A Randomized, Double-blind, Placebo-controlled Study of Anakinra in Pediatric and Adult Patients with Still's Disease
    Schanberg, Laura
    Nigrovic, Peter
    Cooper, Ashley
    Chatham, Winn
    Akoghlanian, Shoghik
    Singh, Namrata
    Rabinovich, C. Egla
    Thatayatikom, Akaluck
    Taxter, Alysha
    Hausmann, Jonathan
    Zdravkovic, Milan
    Ohlman, Sven
    Andersson, Henrik
    Cederholm, Susanna
    Huledal, Gunilla
    Schneider, Rayfel
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 47 - 49
  • [8] A Randomized, Double-Blind, Placebo-Controlled Study of Anakinra in Pediatric and Adult Patients with Still's Disease
    Schanberg, Laura
    Nigrovic, Peter
    Cooper, Ashley
    Chatham, Winn
    Akoghlanian, Shoghik
    Singh, Namrata
    Rabinovich, C. Egla
    Thatayatikom, Akaluck
    Taxter, Alysha
    Hausmann, Jonathan
    Zdravkovic, Milan
    Ohlman, Sven
    Andersson, Henrik
    Cederholm, Susanna
    Huledal, Gunilla
    Schneider, Rayfel
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [10] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137